Rousselot provides collagen-based solutions for the food, health & nutrition, biomedical, and pharmaceutical sectors.

Rousselot

Tyson Foods, Inc., together with its subsidiaries, operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods. The company processes live fed cattle and live market hogs; fabricates dressed beef and pork carcasses into primal and sub-primal meat cuts, as well as case ready beef and pork, and fully cooked meats; raises and processes chickens into fresh, frozen, and value-added chicken products; and supplies poultry breeding stock; sells specialty products, such as hides and meats. It also manufactures and markets frozen and refrigerated food products, including ready-to-eat sandwiches, flame-grilled hamburgers, Philly steaks, pepperoni, bacon, breakfast sausage, turkey, lunchmeat, hot dogs, flour and corn tortilla products, appetizers, snacks, prepared meals, ethnic foods, side dishes, meat dishes, breadsticks, and processed meats under the Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, Aidells, and Gallo Salame brands. The company also offers its products under Tyson and ibp brands. It sells its products through its sales staff to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, live markets, international export companies, and domestic distributors who serve restaurants and food service operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors, as well as through independent brokers and trading companies. The company was founded in 1935 and is headquartered in Springdale, Arkansas.

John W. Tyson

Tyson Foods, Inc.

COLLIDE offers collagen-based products aimed at improving fitness and beauty lifestyles. The products include drinks and gummies containing hydrolyzed collagen and essential vitamins.

COLLIDE

Lime Rock Partners provides growth capital for the energy industry and focuses on building differentiated businesses.

Lime Rock Partners

Rousselot provides collagen-based solutions for the food, health & nutrition, biomedical, and pharmaceutical sectors. It aims to deliver advanced ingredient solutions that enable innovation and contribute to public health.

Manufacturing

Darling Ingredients

Rousselot | 30,098 followers on LinkedIn. Rousselot is the global leader of gelatin and collagen-based solutions. Rousselot is Darling Ingredients&#39; health brand. | Rousselot: Reaching further together

Rousselot is the global leader of collagen-based solutions* for the food, health and nutrition, biomedical and pharmaceutical sectors. We convert the full potential of the collagen molecule into solutions that sustain people’s health and well-being.
Working in partnership with our global customer-base, we deliver advanced ingredient solutions that enable innovation, excite today’s consumers, and contribute to public health.

Global Science & Innovation Director at Rousselot

Elke De Clerck

Denis Rappaport

Ricky Ngiau

Sandor Noordermeer

𝗖𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝘁𝗿𝗲𝗻𝗱𝘀 𝗮𝗻𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝘁 Food ingredients Europe 𝟮𝟬𝟮𝟰! Visit the Rousselot-Gelnex booth (3.1D40) at Fi Europe 2024 to get inspired! Here's what to look forward to: - Insightful presentations: Explore how to differentiate in the high-protein bar market with Tim De Lange , Global Application Center Manager, and Andréa LAUNAY , Market Analyst; - Innovative prototypes: Try our sugar-reduced marshmallows and the ImmuniBoost Gummy Cap, featuring zinc and vitamin C; - Next-gen collagen: Discover Nextida™ GC, designed to target post-meal glucose spikes; - Exciting product concepts: From sugar-free gummies and collagen-infused mocktails to indulgent, shelf-stable protein bars. And that's just the beginning. Learn more about what we’re bringing to Fi Europe in this article from Nutraceutical Business Review 👉 https://hubs.ly/Q02VCM0R0

𝗦𝘁𝗮𝗯𝗶𝗖𝗮𝗽𝘀™ 𝘀𝗲𝗰𝘂𝗿𝗲𝘀 𝗕𝗿𝗮𝘇𝗶𝗹𝗶𝗮𝗻 𝗽𝗮𝘁𝗲𝗻𝘁 ✅ 🇧🇷 We’re thrilled to announce that StabiCaps™, our specialized gelatin technology designed to improve softgel stability, has received a Brazilian patent from the Instituto Nacional da Propriedade Industrial. This new patent, alongside those granted by the European Patent Office and the U.S. Patent and Trademark Office, strengthens our unique and innovative intellectual property portfolio. ‘Securing three major international patents underscores the unique value of our technology’, say Pierre-Albert Thomas , Global Director Functional Ingredients. ‘We’re excited to see how this recognition will open up new opportunities in the rapidly evolving Brazilian health and wellness market.’ Read the press release now 👉 https://hubs.ly/Q02Wq9jy0

Congratulations to The Medicine Maker on its 10-year anniversary! To celebrate this milestone, the publication has shared a story looking back at some of their most popular articles focused on careers and leadership. Great to see that Elke De Clerck ’s interview, exploring the leadership skills required to succeed in the life sciences, has been featured! Read the full article here to discover wisdom and tips on being a leader and advancing your career: https://hubs.ly/Q02Wsm2D0 #Leadership #WomeninSTEM #Careers #Talent

SupplySide West 2024 opens today with the launch of Nextida GC at Rousselot booth #5641. Come and meet our team! Learn how Nextida GC can help to reduce glucose spikes after a meal. #nextida #glucosemanagement

Don't miss out — it's happening tomorrow! Be part of our exclusive webinar on October 31 at 4pm CET/8am PDT and discover all the exciting details about our latest launch, NEXTIDA GC! Register now: https://hubs.ly/Q02Wgypj0 Informa #Nextida #TargetedPeptides

COMPAMED 2024 is just around the corner! Join us at booth 8AK14, to learn more about our pure and consistent medical grade gelatins. Our Quali-Pure and X-Pure gelatins provide: ✅ Controlled endotoxin levels ✅ Batch to batch consistency ✅ GMP compliance ✅ Virus inactivation and traceability Contact us today to learn more or arrange a meeting with our expert team: https://hubs.ly/Q02VgLwT0

🚀 Introducing NEXTIDA GC: a game-changer for the post-meal glucose spike! We’re thrilled to unveil Nextida GC, a new specific collagen peptide composition that naturally targets post-meal blood sugar spikes, opening a new dimension of glucose control. In a first clinical study, researchers observed a significant reduction of the post-meal glucose spike by an average of 42% across healthy participants. The study also demonstrated the incretin effect, in which GLP1 plays a crucial role. ‘We’re immensely excited to take our new step toward decoding the collagen molecule with the release of this first study,’ said Jeroen Colpaert , Executive Vice President, Rousselot. ‘With new science supporting our ingredient’s potential for post-meal glucose metabolism in healthy individuals, we are continuing our commitment to offering the health and wellness industry evidence-based solutions that expand what we know about collagen.’ Launching at SupplySide West 2024 in Las Vegas, Nextida GC is the first commercial launch from Rousselot’s new Nextida innovative platform. Discover more about Nextida GC now: https://hubs.ly/Q02TMLZ_0 #Launch #Collagen #Glucose #TargetedPeptides

🎙️ Explore the benefits of collagen with Paula Ellis on the latest episode of the Sport Life Podcast! 🇪🇸 In this episode, Paula Ellis, nutritionist, fitness influencer, and Key Account Manager at Weider Nutrition , shares her best tips for maintaining a healthy lifestyle and boosting overall wellness. Interviewed by @Yolanda-Vázquez Mazariego, Paula also reveals some delicious and easy-to-make collagen recipes you can try at home! 🍽️ 🎧 Tune in now 👉 https://hubs.ly/Q02SV4-Q0 . Also available on iVoox, Spotify, and Apple Podcasts. #Health #Fitness #Sports #Collagen #CollagenPeptides

Are you struggling to make consistent GelMA to achieve reproducible results? Our research grade GelMA provides a quick solution. With low endotoxin levels and batch traceability, it’s ideal for: ✅ 3D bioprinting ✅ Biofabrication ✅ Tissue engineering Get 3-for-2 on Rousselot GelMA, available on BIO INX today: https://hubs.ly/Q02TQm5Q0 #Bioprinting #TissueEngineering #Gelatin

Metric
Company Name	Rousselot	Tyson Foods, Inc.	COLLIDE	Lime Rock Partners
Symbol		TSN
MSH ID	COM:ROUSSELOT	COM:TYSONFOODS	COM:DRINK-COLLIDE	COM:LRPARTNERS
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Consumer Goods	Consumer Defensive	Consumer Goods	Financial Services & Finance
Industry	Food and Beverage	Agricultural Farm Products	Dietary Supplements	Energy
Country	DE	US	DE	US
Stage
Employee Count		139K
Website	rousselot.com	tysonfoods.com	drink-collide.com	lrpartners.com
LinkedIn	rousselot	tyson-foods	collide-club
Founders

Metric
Market Cap		19.70B
Enterprise Value
Monthly Web Traffic	8.08K	37.47K	6.55K
Web Traffic Growth	-0.47	-0.78	-0.16
Valuation
Raised Capital

Metric
Revenue		53.31B
Revenue (LTM)
Revenue (NTM)
Gross Profit		3.63B
EBITDA		2.97B
Operating Income		1.41B
Net Income		800M
EPS		2.31
Diluted EPS		2.25
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.06
Operating Profit Margin		0.01
EBITDA Margin		0.06
Net Profit Margin		-0.00
Return on Equity		-0.00
Return on Assets		-0.00
Return on Capital Employed		0.01

COM:ROUSSELOT

Rousselot

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-31.70
P/B Ratio		1.12
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		0.43
EV Multiple		8.34

Metric
Days Sales Outstanding		17.09
Days Payables Outstanding		18.84
Days Inventory Outstanding		36.87
Operating Cycle		53.15
Cash Conversion Cycle		36.78
Asset Turnover		1.74

Metric
Operating Cash Flow		1.75B
Free Cash Flow		-187M
Cash Flow to Debt		0.24
Operating Cash Flow/Sales		0.04
Free Cash Flow Yield		-0.01

Metric
Cash & Equivalents		1.72B
Accounts Receivable		136M
Inventory		5.20B
Goodwill		9.82B
Debt to Capitalization		0.38
Debt to Assets		0.26
Current Ratio		1.34
Quick Ratio		0.95

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue